Leukoencephalopathies in mitochondrial disorders: Clinical and MRI findings

Journal of Neuroimaging

Volumn 22, Issue 3, 2012, Pages

  Finsterer, Josef ^a   Zarrouk Mahjoub, Sinda ^b  

^a DANUBE UNIVERSITY KREMS   (Austria)

^b UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

Central nervous system involvement; Leukodystrophy; Mitochondrial disorder; Mitochondriopathy

Indexed keywords

CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; CLINICAL ASSESSMENT; DIFFERENTIAL DIAGNOSIS; GLIA CELL; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; INFANTILE ONSET SPINOCEREBELLAR ATAXIA; KEARNS SAYRE SYNDROME; LEBER HEREDITARY OPTIC NEUROPATHY; LEIGH DISEASE; LEUKOENCEPHALOPATHY; LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT WITH LACTACIDOSIS; MELAS SYNDROME; MERRF SYNDROME; MITOCHONDRIAL DNA DISORDER; MNGIE SYNDROME; NERVE CELL NECROSIS; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PEARSON SYNDROME; PROGNOSIS; REVIEW; WHITE MATTER;

ADOLESCENT; ADULT; BRAIN; CHILD; FEMALE; HUMANS; LEUKOENCEPHALOPATHIES; MAGNETIC RESONANCE IMAGING; MITOCHONDRIAL DISEASES; YOUNG ADULT;

EID: 84863782373     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2011.00693.x     Document Type: Review

References (102)

1. Finsterer J. Central nervous system manifestations of mitochondrial disorders. Acta Neurol Scand 2006;114:217-238.
2. Finsterer J, Jarius C, Eichberger H. Phenotype variability in 130 adult patients with respiratory chain disorders. J Inherit Metab Dis 2001;24:560-576.
3. Chi CS, Lee HF, Tsai CR, et al. Cranial magnetic resonance imaging findings in children with nonsyndromic mitochondrial diseases. Pediatr Neurol 2011;44:171-176.
4. Köhler W. Leukodystrophies with late disease onset: an update. Curr Opin Neurol 2010;23:234-241.
5. Leigh D. Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry 1951;14:216-221.
6. Kim KW, MacFall JR, Payne ME. Classification of white matter lesions on magnetic resonance imaging in elderly persons. Biol Psychiatry 2008;64:273-280.
7. Apostolova LG, White M, Moore SA, et al. Deep white matter pathologic features in watershed regions: a novel pattern of central nervous system involvement in MELAS. Arch Neurol 2005;62:1154-1156.
8. Kearns TP, Sayre GP. Retinitis pigmentosa, external ophthalmophegia, and complete heart block: unusual syndrome with histologic study in one of two cases. AMA Arch Ophthalmol 1958;60:280-289.
9. Kaufman KR, Zuber N, Rueda-Lara MA, et al. MELAS with recurrent complex partial seizures, nonconvulsive status epilepticus, psychosis, and behavioural disturbances: case analysis with literature review. Epilepsy Behav 2010;18:494-497.
10. Sproule DM, Kaufmann P. Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann N Y Acad Sci 2008;1142:133-158.
11. Fromont I, Nicoli F, Valéro R, et al. Brain anomalies in maternally inherited diabetes and deafness syndrome. J Neurol 2009;256:1696-1704.
12. Guo Y, Guo Z, Chen L, et al. Clinical, pathologic and genetic studies on mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes. Chin Med J (Engl) 1997;110:851-855.
13. Huang CC, Wai YY, Chu NS, et al. Mitochondrial encephalomyopathies: CT and MRI findings and correlations with clinical features. Eur Neurol 1995;35:199-205.
14. Wang Z, Qi XK, Yao S, et al. Phenotypic patterns of MELAS/LS overlap syndrome associated with m.13513G A mutation, and neuropathological findings in one autopsy case. Neuropathology 2010;30:606-614.
15. Tanahashi C, Nakayama A, Yoshida M, et al. MELAS with the mitochondrial DNA 3243 point mutation: a neuropathological study. Acta Neuropathol 2000;99:31-38.
16. Yokoyama T, Hasegawa K, Obama R, et al.MELAS with diffuse degeneration of the cerebral white matter: report of an autopsy case. Neuropathology 2010;30:56-60.
17. Tsuchiya K, Miyazaki H, Akabane H, et al. MELAS with prominent white matter gliosis and atrophy of the cerebellar granular layer: a clinical, genetic, and pathological study. Acta Neuropathol 1999;97:520-524.
18. Pou Serradell A, Corominas J, Vilaseca MA, et al. Mitochondrial myopathy and leukoencephalopathy in twins of different sexes. Rev Neurol (Paris) 1991;147:497-500.
19. Fujii T, Okuno T, Ito M, et al. CT, MRI, and autopsy findings in brain of a patient with MELAS. Pediatr Neurol 1990;6:253-256.
20. Terauchi A, Tamagawa K, Morimatsu Y, et al. An autopsy case of mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) with a point mutation of mitochondrial DNA. Brain Dev 1996;18:224-229.
21. Tsujikawa T, Yoneda M, Shimizu Y, et al. Pathophysiologic evaluation of MELAS strokes by serially quantified MRS and CASL perfusion images. Brain Dev 2010;32:143-149.
22. Wilichowski E, Pouwels PJ, Frahm J, et al. Quantitative proton magnetic resonance spectroscopy of cerebral metabolic disturbances in patients with MELAS. Neuropediatrics 1999;30:256-263.
23. Lindroos MM, Borra RJ, Parkkola R, et al. Cerebral oxygen and glucose metabolism in patients with mitochondrial m.3243A>G mutation. Brain 2009;132:3274-3284.
24. Stratilová L, Zeman J, Houst'ková H, et al. Various manifestations of the A8344G mtDNA heteroplasmic mutation in 4 families with the MERRF syndrome. Cas Lek Cesk 1999;138:401-405.
25. Lorenzoni PJ, Scola RH, Kay CS, et al. MERRF: clinical features, muscle biopsy and molecular genetics in Brazilian patients. Mitochondrion 2011;11:528-532.
26. Perez F, Anne O, Debruxelles S, et al. Leber's optic neuropathy associated with disseminated white matter disease: a case report and review. Clin Neurol Neurosurg 2009;111:83-86.
27. Cortelli P, Montagna P, Pierangeli G, et al. Clinical and brain bioenergetics improvement with idebenone in a patient with Leber's hereditary optic neuropathy: a clinical and 31P-MRS study. J Neurol Sci 1997;148:25-31.
28. Guerriero S, Vetrugno M, Ciracì L, et al. Bilateral progressive visual loss in an epileptic, mentally retarded boy. Middle East Afr J Ophthalmol 2011;18:67-70.
29. Lev D, Yanoov-Sharav M, Watemberg N, et al. White matter abnormalities in Leber's hereditary optic neuropathy due to the 3460 mitochondrial DNA mutation. Eur J Paediatr Neurol 2002;6:121-123.
30. Kovács GG, Höftberger R, Majtényi K, et al. Neuropathology of white matter disease in Leber's hereditary optic neuropathy. Brain 2005;128:35-41.
31. Meire FM, Van Coster R, Cochaux P, et al. Neurological disorders in members of families with Leber's hereditary optic neuropathy (LHON) caused by different mitochondrial mutations. Ophthalmic Genet 1995;16:119-126.
32. Küker W, Weir A, Quaghebeur G, et al. White matter changes in Leber's hereditary optic neuropathy: MRI findings. Eur J Neurol 2007;14:591-593.
33. Harding AE, Sweeney MG, Miller DH, et al. Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain 1992;115:979-989.
34. Cawley N, Molloy A, Cassidy L, et al. Late-onset progressive visual loss in a man with unusual MRI findings: MS, Harding's, Leber's or Leber's Plus? Ir J Med Sci 2010;179:599-601.
35. Pato-Pato A, Cimas-Hernando I, Lorenzo-González JR. Leber's optic neuropathy: a case report. Rev Neurol 2006;42:22-24.
36. Ostojic J, Jancic J, Kozic D, et al. Brain white matter 1 H MRS in Leber optic neuropathy mutation carriers. Acta Neurol Belg 2009;109:305-309.
37. Barcella V, Rocca MA, Bianchi-Marzoli S, et al. Evidence for retrochiasmatic tissue loss in Leber's hereditary optic neuropathy. Hum Brain Mapp 2010;31:1900-1906.
38. Bosbach S, Kornblum C, Schröder R, et al. Executive and visuospatial deficits in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome. Brain 2003;126:1231-1240.
39. Moslemi AR, Melberg A, Holme E, et al. Autosomal dominant progressive external ophthalmoplegia: distribution of multiple mitochondrial DNA deletions. Neurology 1999;53(1):79-84.
40. Van Hove JL, Cunningham V, Rice C, et al. Finding twinkle in the eyes of a 71-year-old lady: a case report and review of the genotypic and phenotypic spectrum of TWINKLE-related dominant disease. Am J Med Genet A 2009;149A:861-867.
41. Heidenreich JO, Klopstock T, Schirmer T, et al. Chronic progressive external ophthalmoplegia: MR spectroscopy and MR diffusion studies in the brain. AJR Am J Roentgenol 2006;187:820-824.
42. Mayer WJ, Remy M, Rudolph G. Kearns-Sayre syndrome: a mitochondrial disease (OMIM #530000). Ophthalmologe 2011;108:459-462.
43. Kamata Y, Mashima Y, Yokoyama M, et al. Patient with Kearns-Sayre syndrome exhibiting abnormal magnetic resonance image of the brain. J Neuroophthalmol 1998;18:284-288.
44. Chu BC, Terae S, Takahashi C, et al. MRI of the brain in the Kearns-Sayre syndrome: report of four cases and a review. Neuroradiology 1999;41:759-764.
45. Hourani RG, Barada WM, Al-Kutoubi AM, et al. Atypical MRI findings in Kearns-Sayre syndrome: T2 radial stripes. Neuropediatrics 2006;37:110-113.
46. Duning T, Deppe M, Keller S, Mohammadi S, et al. Diffusion tensor imaging in a case of Kearns-Sayre syndrome: striking brainstem involvement as a possible cause of oculomotor symptoms. J Neurol Sci 2009;281:110-112.
47. Tanji K, DiMauro S, Bonilla E. Disconnection of cerebellar Purkinje cells in Kearns-Sayre syndrome. J Neurol Sci 1999;166:64-70.
48. Pineda M, Ormazabal A, López-Gallardo E, et al. Cerebral folate deficiency and leukoencephalopathy caused by a mitochondrial DNA deletion. Ann Neurol 2006;59:394-398.
49. Müller W, Mennel HD, Bewermeyer K, et al. Is there a final common pathway in mitochondrial encephalomyopathies? Considerations based on an autopsy case of Kearns-Sayre syndrome. Clin Neuropathol 2003;22:240-245.
50. McKelvie PA, Morley JB, Byrne E, et al. Mitochondrial encephalomyopathies: a correlation between neuropathological findings and defects in mitochondrial DNA. J Neurol Sci 1991;102:51-60.
51. Valanne L, Ketonen L, Majander A, et al. Neuroradiologic findings in children with mitochondrial disorders. Am J Neuroradiol 1998;19:369-377.
52. Lee HF, Lee HJ, Chi CS, et al. The neurological evolution of Pearson syndrome: case report and literature review. Eur J Paediatr Neurol 2007;11:208-214.
53. Roels F, Verloo P, Eyskens F, et al. Mitochondrial mosaics in the liver of 3 infants with mtDNA defects. BMC Clin Pathol 2009;9:4-12.
54. Ariga H, Takahashi S, Miyabayashi S, et al. Leigh syndrome: serial CT and MR imaging findings. Nippon Igaku Hoshasen Gakkai Zasshi 1996;56:839-845.
55. Cavanagh JB, Harding BN. Pathogenic factors underlying the lesions in Leigh's disease: tissue responses to cellular energy deprivation and their clinico-pathological consequences. Brain 1994;117:1357-1376.
56. Hung PC, Wang HS. A previously undescribed leukodystrophy in Leigh syndrome associated with T9176C mutation of the mitochondrial ATPase 6 gene. Dev Med Child Neurol 2007;49:65-67.
57. Ostergaard E, Rodenburg RJ, van den Brand M, et al. Respiratory chain complex I deficiency due to NDUFA12 mutations as a new cause of Leigh syndrome. J Med Genet 2011;48:737-740.
58. Rouco Axpe I, Garaizar Axpe C, Labairu Echevarría M, et al. Mitochondrial leukoencephalopathy of infancy: is it an early expression of Leigh syndrome? Neurologia 2003;18:241-247.
59. Sobreira C, Marques W Jr, Pontes Neto OM, et al. Leigh-like syndrome with the T8993G mutation in the mitochondrial ATPase 6 gene: long-term follow-up discloses a slowly progressive course. J Neurol Sci 2009;278:132-134.
60. Zhang Y, Sun F, Yang YL, et al. Leigh syndrome due to pyruvate dehydrogenase E1 alpha subunit gene mutation: a complicated and difficult case study. Zhongguo Dang Dai Er Ke Za Zhi 2007;9:216-219.
61. Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999;283:689-692.
62. Carod-Artal FJ, Herrero MD, Lara MC, et al. Cognitive dysfunction and hypogonadotrophic hypogonadism in a Brazilian patient with mitochondrial neurogastrointestinal encephalomyopathy and a novel ECGF1 mutation. Eur J Neurol 2007;14:581-585.
63. Laforce R Jr, Valdmanis PN, Dupré N, et al. A novel TYMP mutation in a French Canadian patient with mitochondrial neurogastrointestinal encephalomyopathy. Clin Neurol Neurosurg 2009;111:691-694.
64. Papadimitriou A, Comi GP, Hadjigeorgiou GM, et al. Partial depletion and multiple deletions of muscle mtDNA in familial MNGIE syndrome. Neurology 1998;51:1086-1092.
65. Gamez J, Minoves T. Abnormal brainstem auditory evoked responses in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): evidence of delayed central conduction time. Clin Neurophysiol 2006;117:2385-2391.
66. Honzík T, Tesarová M, Hansíková H, et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Cas Lek Cesk 2006;145:665-670.
67. Schüpbach WM, Vadday KM, Schaller A, et al. Mitochondrial neurogastrointestinal encephalomyopathy in three siblings: clinical, genetic and neuroradiological features. J Neurol 2007;254:146-153.
68. Hakonen AH, Isohanni P, Paetau A, et al. Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion. Brain 2007;130:3032-3040.
69. Scheper GC, van der Klok T, van Andel RJ, et al. Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat Genet 2007;39:534-539.
70. Isohanni P, Linnankivi T, Buzkova J, et al. DARS2 mutations in mitochondrial leukoencephalopathy and multiple sclerosis. J Med Genet 2010;47:66-70.
71. Uluc K, Baskan O, Yildirim KA, et al. Leukoencephalopathy with brain stem and spinal cord involvement and high lactate: a genetically proven case with distinct MRI findings. J Neurol Sci 2008;273:118-122.
72. Lin J, Chiconelli Faria E, Da Rocha AJ, Rodrigues Masruha M, et al. Leukoencephalopathy with brainstem and spinal cord involvement and normal lactate: a new mutation in the DARS2 gene. J Child Neurol 2010;25:1425-1428.
73. Koskinen T, Valanne L, Ketonen LM, et al. Infantile-onset spinocerebellar ataxia: MR and CT findings. Am J Neuroradiol 1995;16:1427-1433.
74. Chung KW, Suh BC, Cho SY, et al. Early-onset Charcot-Marie-Tooth patients with mitofusin 2 mutations and brain involvement. J Neurol Neurosurg Psychiatry 2010;81:1203-1206.
75. Nicolino M, Ferlin T, Forest M, et al. Identification of a large-scale mitochondrial deoxyribonucleic acid deletion in endocrinopathies and deafness: report of two unrelated cases with diabetes mellitus and adrenal insufficiency, respectively. J Clin Endocrinol Metab 1997;82:3063-3067.
76. Nakai A, Goto Y, Fujisawa K, et al. Diffuse leukodystrophy with a large-scale mitochondrial DNA deletion. Lancet 1994;343:1397-1398.
77. Jaksch M, Horvath R, Horn N, et al. Homozygosity (E140K) in SCO2 causes delayed infantile onset of cardiomyopathy and neuropathy. Neurology 2001;57:1440-1446.
78. Spinazzola A, Viscomi C, Fernandez-Vizarra E, et al. MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat Genet 2006;38:570-575.
79. Karadimas CL, Vu TH, Holve SA, et al. Navajo neurohepatopathy is caused by a mutation in the MPV17 gene. Am J Hum Genet 2006;79:544-548.
80. Isohanni P, Hakonen AH, Euro L, et al. POLG1 manifestations in childhood. Neurology 2011;76:811-815.
81. Van Goethem G, Luoma P, Rantamäki M, et al. POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement. Neurology 2004;63:1251-1257.
82. Zafeiriou DI, Rodenburg RJ, Scheffer H, et al. MR spectroscopy and serial magnetic resonance imaging in a patient with mitochondrial cystic leukoencephalopathy due to complex I deficiency and NDUFV1 mutations and mild clinical course. Neuropediatrics 2008;39:172-175.
83. Kang PB, Hunter JV, Melvin JJ, et al. Infantile leukoencephalopathy owing to mitochondrial enzyme dysfunction. J Child Neurol 2002;17:421-428.
84. Weinstock A, Giglio P, Cohen ME, et al. Diffuse magnetic resonance imaging white-matter changes in a 15-year-old boy with mitochondrial encephalomyopathy. J Child Neurol 2002;17:47-49.
85. Lebre AS, Rio M, Faivre d'Arcier L, et al. A common pattern of brain MRI imaging in mitochondrial diseases with complex I deficiency. J Med Genet 2011;48:16-23.
86. Lindner A, Hofmann E, Naumann M, et al. Clinical, morphological, biochemical, and neuroradiological features of mitochondrial encephalomyopathies. Presentation of 19 patients. Mol Cell Biochem 1997;174:297-303.
87. Majoie CB, Akkerman EM, Blank C, et al. Mitochondrial encephalomyopathy: comparison of conventional MR imaging with diffusion-weighted and diffusion tensor imaging: case report. Am J Neuroradiol 2002;23:813-816.
88. de Lonlay-Debeney P, von Kleist-Retzow JC, Hertz-Pannier L, et al. Cerebral white matter disease in children may be caused by mitochondrial respiratory chain deficiency. J Pediatr 2000;136:209-214.
89. Racine AC, Blanchot G, Le Vaillant C, et al. Pregnancy in a patient with mitochondrial disease. J Gynecol Obstet Biol Reprod (Paris) 2004;33:131-139.
90. Filosto M, Tomelleri G, Tonin P, et al. Neuropathology of mitochondrial diseases. Biosci Rep 2007;27:23-30.
91. Kimura S, Kobayashi T, Amemiya F. Myelin splitting in the spongy lesion in Leigh encephalopathy. Pediatr Neurol 1991;7:56-58.
92. Mizuguchi M, Hayashi M, Nakano I, et al. Concentric structure of thalamic lesions in acute necrotizing encephalopathy. Neuroradiology 2002;44:489-493.
93. Schmidt-Sidor B, Mierzewska H, Turzyniecka M, et al. Neurodegenerative disease in infants with multiple congenital malformations-report of two cases. Folia Neuropathol 2004;42:221-226.
94. Barkhof F, Scheltens P. Imaging of white matter lesions. Cerebrovasc Dis 2002;13(suppl 2):21-30.
95. Ducreux D, Nasser G, Lacroix C, et al. MR diffusion tensor imaging, fiber tracking, and single-voxel spectroscopy findings in an unusual MELAS case. Am J Neuroradiol 2005;26:1840-1844.
96. Friedman SD, Shaw DW, Ishak G, et al. The use of neuroimaging in the diagnosis of mitochondrial disease. Dev Disabil Res Rev 2010;16:129-135.
97. Sacher M, Fatterpekar GM, Edelstein S, et al. MRI findings in an atypical case of Kearns-Sayre syndrome: a case report. Neuroradiology 2005;47:241-244.
98. Hung PC, Wang HS. A previously undescribed leukodystrophy in Leigh syndrome associated with T9176C mutation of the mitochondrial ATPase 6 gene. Dev Med Child Neurol 2007;49:65-67.
99. Vedolin L, de Souza CF, Silveira RS, et al. Conventional MRI and MR spectroscopy in nonclassical mitochondrial disease: report of three patients with mitochondrial DNA deletion. Childs Nerv Syst 2006;22:1355-1359.
100. Wray SH, Provenzale JM, Johns DR, et al. MR of the brain in mitochondrial myopathy. Am J Neuroradiol 1995;16:1167-1173.
101. Arii J, Tanabe Y. Leigh syndrome: serial MR imaging and clinical follow-up. Am J Neuroradiol 2000;21:1502-1509.
102. Barragán-Campos HM, Vallée JN, Lô D, et al. Brain magnetic resonance imaging findings in patients with mitochondrial cytopathies. Arch Neurol 2005;62:737-742.